FHIT and chronic myelogenous leukemia, BCR-ABL1 positive: In hematological malignancies, FHIT methylation has been seen in some cases of myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL), and chronic myelogenous leukemia (CML) [27–29].